STOCK TITAN

Bio-Techne Declares Dividend

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
dividends

Rhea-AI Summary

Bio-Techne Corporation (NASDAQ: TECH) announced a quarterly dividend of $0.32 per share for the period ending December 31, 2020. This dividend will be payable on February 26, 2021, to shareholders on record as of February 12, 2021. Bio-Techne, a global life sciences firm, reported approximately $739 million in net sales for fiscal 2020, enhancing its appeal as an investment option. The Board will consider future dividends quarterly.

Loading...
Loading translation...

Positive

  • Declared a quarterly dividend of $0.32 per share, enhancing shareholder returns.
  • Generated approximately $739 million in net sales in fiscal 2020, showing solid financial performance.

Negative

  • None.
Argus Session date unavailable
+10.79% session move Open Argus
Details

News Market Reaction – TECH

The recorded move for TECH in the trading session of this news was +10.79%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MINNEAPOLIS, Feb. 2, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended December 31, 2020. The quarterly dividend will be payable February 26, 2021 to all common shareholders of record on February 12, 2021. Future cash dividends will be considered by the Board of Directors on a quarterly basis.

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $739 million in net sales in fiscal 2020 and has over 2,300 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio-techne.com.

Contact:

David Clair, Senior Director, Investor Relations & Corporate Development


David.Clair@bio-techne.com


612-656-4416

 

Bio-Techne

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bio-techne-declares-dividend-301219881.html

SOURCE Bio-Techne Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the dividend amount declared by Bio-Techne Corporation on February 2, 2021?

Bio-Techne Corporation declared a dividend of $0.32 per share on February 2, 2021.

When will the dividend be paid to shareholders?

The dividend will be paid on February 26, 2021.

What is the record date for the dividend payment from Bio-Techne Corporation?

The record date for the dividend payment is February 12, 2021.

How often will Bio-Techne Corporation consider dividends?

Bio-Techne Corporation will consider future cash dividends on a quarterly basis.

Keep reading